Fondaparinux Sodium, Clinically, it is used for the prevention of deep vein .thrombosis in patients who have had orthopedic surgery as well as for the treatment of deep vein thrombosis and pulmonary embolism. Reference standards of Fondaparinux Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Fondaparinux Sodium
Catalogue No.:PA 06 1660000
CAS :
Molecular Formula : C31H43N3Na10O49S8
Molecular Weight : 1728.03
Methyl 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-α-D-glucopyranoside 6-(Hydrogen Sulfate) Sodium Salt (1:4);
Catalogue No.:PA 06 1661000
Molecular Formula : C13H21NNa4O19S3
Molecular Weight : 683.44
Methyl 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-α-D-glucopyranoside 6-(Hydrogen Sulfate)
Catalogue No.:PA 27 0024263
Molecular Formula : C13H21NO19S3
Molecular Weight : 591.48
Fondaparinux Sodium System Suitability Mixture A Solution (1282731)
Catalogue No.:PA USP 1282731
Molecular Formula : NA
Molecular Weight : NA
Fondaparinux Sodium Impurity 1
Catalogue No.:PA 06 1661001
Molecular Formula : C31H42N3Na11O52S9
Molecular Weight : 1830.07
Fondaparinux Sodium Impurity 2
Catalogue No.:PA 06 1661002
Molecular Formula : C32H44N3Na9O47S7
Molecular Weight : 1654.01
Fondaparinux Sodium Impurity 3
Catalogue No.:PA 06 1661003
Molecular Formula : C38H55N3Na10O49S8
Molecular Weight : 1824.21
Fondaparinux Sodium Impurity 4
Catalogue No.:PA 06 1661004
Molecular Formula : C31H44N3Na9O46S7
Molecular Weight : 1626
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
